Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steroid-induced osteoporosis.

R S Bockman1, S A Weinerman

  • 1Cornell University Medical College, New York, New York.

The Orthopedic Clinics of North America
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Low volumetric bone density is a risk factor for early complications after spine fusion surgery.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Vitamin D and bisphosphonate response.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same author

The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Same author

Effects of heat shock, stannous chloride, and gallium nitrate on the rat inflammatory response.

Cell stress & chaperones·2001
Same author

Bone strength and related traits in HcB/Dem recombinant congenic mice.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2001
Same journal

New Technologies.

The Orthopedic clinics of North America·2026
Same journal

Recent Innovations and Applications of Custom 3D Printed Cages for Critical Bone Defects in Foot and Ankle Surgery.

The Orthopedic clinics of North America·2026
Same journal

Application of New Technologies: Patient-specific Instrumentation and Artificial Intelligence in the Field of Foot and Ankle.

The Orthopedic clinics of North America·2026
Same journal

Robotic-Assisted Latissimus Dorsi Transfers Around the Shoulder.

The Orthopedic clinics of North America·2026
Same journal

Blood Flow Restriction Therapy for the Upper Extremity: An Emerging Adjunct for Patient Recovery and Rehabilitation.

The Orthopedic clinics of North America·2026
Same journal

The Emerging Roles for 3 Dimensional Printing in Orthopedics: Applications, Evidence, and Future Directions.

The Orthopedic clinics of North America·2026
See all related articles

Prolonged glucocorticoid use accelerates bone loss, causing osteopenia and fractures, especially in the first year. Therapies targeting bone resorption may prevent this steroid-induced osteoporosis.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Pharmacology

Background:

  • Glucocorticoids are widely used but induce significant bone loss, leading to osteopenia and increased fracture risk.
  • Cortisol excess clinically manifests as progressive demineralization, predominantly affecting trabecular bone and causing vertebral and rib fractures.

Purpose of the Study:

  • To summarize the mechanisms and clinical presentation of glucocorticoid-induced bone loss.
  • To highlight the temporal dynamics of bone loss and factors influencing its rate.
  • To suggest potential therapeutic strategies for mitigating steroid-induced osteoporosis.

Main Methods:

  • Review of clinical presentations and histological findings associated with glucocorticoid therapy.
  • Analysis of bone remodeling rates and their correlation with bone loss.

Related Experiment Videos

  • Discussion of adjuvant therapies aimed at inhibiting bone resorption.

    • Main Results:

    • Bone dissolution is most rapid during initial steroid therapy, with up to 20% trabecular bone loss in the first year.
    • Bone loss rate is highest in individuals with high bone remodeling rates.
    • Histological changes include decreased trabecular volume, increased osteoclast activity, and reduced bone formation and mineralization.

    Conclusions:

    • Glucocorticoid administration leads to accelerated bone loss, primarily affecting trabecular bone and increasing fracture incidence.
    • Adjuvant medical therapies designed to block accelerated bone resorption show promise in protecting against steroid-induced osteoporosis.